Certified by Founder Lodge
Outrun Therapeutics
United Kingdom - Dundee, Scotland
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 19 ,2024 | Seed | $10,000,000 |
M Ventures(Netherlands)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
zymtrace | $12,200,000 | (Mar 12, 2026)
